Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody‐Drug Conjugates

Antibody‐drug conjugates are important molecular entities in the treatment of cancer, with 8 antibody‐drug conjugates approved by the US Food and Drug Administration since 2000 and many more in early‐ and late‐stage clinical development. These conjugates combine the target specificity of monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunze, Chen, Shang‐Chiung, Chen, Yuan, Girish, Sandhya, Kågedal, Matts, Lu, Dan, Lu, Tong, Samineni, Divya, Jin, Jin Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756373/
https://www.ncbi.nlm.nih.gov/pubmed/33205423
http://dx.doi.org/10.1002/jcph.1720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756373/
https://www.ncbi.nlm.nih.gov/pubmed/33205423
http://dx.doi.org/10.1002/jcph.1720

Ejemplares similares